Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa

Table 4 Virologic response to antiretroviral therapy among HIV-1-infected children

Duration of follow-up, months	Children with viral load measurement^a(%)	Children with HIV-1 viral load <100 copies/ml (%)^b
3	39/54 (72.2%)	21 (53.9%)
6	38/50 (76%)	24 (63.2%)
12	36/38 (94.7%)	20 (55.6%)
18	27/34 (79.4%)	14 (51.9%)
24	22/28 (78.6%)	8 (36.4%)
30	18/21 (85.7%)	9 (50%)
36	12/16 (75%)	7 (58.3%)

^a Denominators represent the number of children with the corresponding length of follow-up.
^b Percentage of those with a viral load measurement at each time point.

ISSN: 1471-2431